Will the nanomedicine "patent land grab" thwart commercialization?

被引：16

作者：

Bawa, Raj ^{[1
,2
,3
]}

机构：

[1] Bawa Biotechnol Consulting LLC, 21005 Starflower Way, Ashburn, VA 20147 USA

[2] Northern Virginia Community Coll, Annandale, VA 22003 USA

[3] Rensselaer Polytech Inst, Troy, NY USA

来源：

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2005年 / 1卷 / 04期

关键词：

D O I：

10.1016/j.nano.2005.10.009

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

引用

页码：346 / 350

页数：5

共 39 条

[21]

GARDNER E, 2003, CORP COUNS, P104

[22]

GRUENWALD J, 2004, SMALL TIMES

[23]

Hsieh T, 2003, IP LAW BUS, V20-3

[24] Longitudinal patent analysis for nanoscale science and engineering: Country, institution and technology field [J].

Huang, Z ;

Chen, HC ;

Yip, A ;

Ng, G ;

Guo, F ;

Chen, ZK ;

Roco, MC .

JOURNAL OF NANOPARTICLE RESEARCH, 2003, 5 (3-4) :333-363

[25] Patent prescription [J].

Jaffe, AB ;

Lerner, J .

IEEE SPECTRUM, 2004, 41 (12) :38-43

[26]

Lawrence S, 2002, RED HERRING, V119

[27]

Merrill Stephen A., 2004, A Patent System for the 21st Century

[28]

MILLER JC, 2004, HDB NANOTECHNOLOGY B

[29]

MITTAL AK, 2005, GAO051008T

[30] Patents on human genes: An analysis of scope and claims [J].

Paradise, J ;

Andrews, L ;

Holbrook, T .

SCIENCE, 2005, 307 (5715) :1566-1567

← 1 2 3 4 →